|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
7
|
Resverlogix Corp.
|
Jun 22, 2020 12:14PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
6
|
Resverlogix Corp.
|
Jun 22, 2020 12:26PM
|
|
Re: Report of exempt distribution
|
1
|
Resverlogix Corp.
|
Jul 01, 2020 02:40PM
|
|
Re: Restricted Share Units - approx. 5 million
|
7
|
Resverlogix Corp.
|
Jul 07, 2020 11:39AM
|
|
Re: Restricted Share Units - approx. 5 million
|
3
|
Resverlogix Corp.
|
Jul 07, 2020 02:39PM
|
|
Re: Restricted Share Units - approx. 5 million
|
3
|
Resverlogix Corp.
|
Jul 07, 2020 02:43PM
|
|
Re: Prospects for resverlogix
|
10
|
Resverlogix Corp.
|
Jul 15, 2020 11:47AM
|
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
5
|
Zenith Epigenetics
|
Jul 16, 2020 04:45PM
|
|
Re: Name Confusion
|
1
|
Zenith Epigenetics
|
Jul 26, 2020 09:29PM
|
|
Re: Notice of exempt distribution
|
5
|
Zenith Epigenetics
|
Jul 28, 2020 01:01PM
|
|
Re: Name Confusion
|
6
|
Zenith Epigenetics
|
Jul 29, 2020 01:00PM
|
|
Re: Exercise of options Norma Biln
|
4
|
Resverlogix Corp.
|
Jul 29, 2020 01:29PM
|
|
Re: Name Confusion
|
2
|
Zenith Epigenetics
|
Jul 29, 2020 03:20PM
|
|
Re: Exercise of options Norma Biln
|
3
|
Resverlogix Corp.
|
Jul 29, 2020 03:29PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Aug 07, 2020 11:28AM
|
|
Re: Finance
|
6
|
Resverlogix Corp.
|
Aug 07, 2020 05:41PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Aug 07, 2020 05:45PM
|
|
Re: Name Confusion
|
6
|
Zenith Epigenetics
|
Aug 12, 2020 12:16PM
|
|
Re: Response & what I will attempt...
|
1
|
Zenith Epigenetics
|
Aug 14, 2020 11:26AM
|
|
Re: Why is "Going it Alone" out of the question??
|
8
|
Resverlogix Corp.
|
Aug 15, 2020 12:37PM
|
